SCHEMBL12480732

SCHEMBL12480732

C[C@](CO)(CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cnn[nH]1)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.69
ACE P12821 4/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19875312 1.00 MME (0.69) MMEACE
SCHEMBL12480836 1.00 MME (0.69) MMEACE
SCHEMBL11970038 1.00 MME (0.69) MMEACE
SCHEMBL11969569 1.00 MME (0.69) MMEACE
SCHEMBL19888572 0.92 MME (0.60) MMEACE
SCHEMBL18411187 0.92 MME (0.60) MMEACE
SCHEMBL18410999 0.92 MME (0.60) MMEACE
SCHEMBL12481787 0.92 MME (0.68) MMEACE
SCHEMBL11969803 0.92 MME (0.68) MMEACE
SCHEMBL11969787 0.91 MME (0.69) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675795-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-12-25 EP disclosed
WO-2012112742-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-08-23 WO disclosed